Ketan Mehta
Foot & Ankle Surgery · Clearwater, FLNPI 1992293849
Payments from drug & device makers
Across 73 payments — averaging $83.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Southern Edge Orthopaedics, Inc.$1K
- Paragon 28, Inc.$242
- Innovation Technologies Inc$193
- Treace Medical Concepts, Inc.$148
- Amgen$101
- plus $759 from 19 others
What the payments were for
- Travel & lodging$2,39740%
- Food & beverage$2,47141%
- Education$1,20020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 30 | $3,425 |
| Southern Edge Orthopaedics, Inc. | 1 | $1,200 |
| Paragon 28, Inc. | 2 | $242 |
| Innovation Technologies Inc | 1 | $193 |
| Treace Medical Concepts, Inc. | 2 | $148 |
| Amgen(2 entities) | 5 | $101 |
| Paratek Pharmaceuticals, Inc. | 5 | $93 |
| Integra Lifesciences Corporation | 1 | $92 |
| Smith+Nephew | 4 | $76 |
| Ossio Inc | 1 | $71 |
| Nevro Corp. | 3 | $60 |
| Abbott | 2 | $47 |
| Medtronic | 2 | $38 |
| Bioventus LLC | 2 | $37 |
| Coastal Medical Technologies LLC | 1 | $35 |
| Acera Surgical, Inc. | 2 | $35 |
| Convatec Inc. | 1 | $30 |
| Organogenesis Inc. | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $19 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Orpyx Medical Technologies US Inc. | 1 | $18 |
| Next Science LLC | 1 | $16 |
| Kerecis Limited | 1 | $15 |
| Iroko Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHOLOC 2 LAPIFUSE$1,355
- ORTHOLOC 3DI$915
- Irrisept$193
- AUGMENT INJECTABLE$150
- ALLOWRAP$150
- Portfolio$133
- Actishield$131
- INBONE$128
- JAWS$109
How this compares
$6,068 in reported general payments places this provider in the 65th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 250 | $4,562 |
| Ammonium Lactate | 104 | $3,605 |
| Methylprednisolone | 34 | $275 |
| Cephalexin | 35 | $254 |
| Clotrimazole | 19 | $162 |
| Doxycycline Hyclate | 20 | $108 |
| Meloxicam | 50 | $97 |
| Terbinafine Hcl | 11 | $75 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Clearwater
- Jason LevyClearwater$375K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.